Non-Hodgkin’s lymphoma (NHL) can indeed cause neurological complications, and these complications arise through several mechanisms related to the disease itself, its spread, immune system reactions, and treatments. Understanding how NHL affects the nervous system requires looking at both direct and indirect effects on the brain, spinal cord, peripheral nerves, and related structures.
First, NHL can directly involve the central nervous system (CNS), which includes the brain and spinal cord. When lymphoma cells grow in these areas, it is called primary central nervous system lymphoma (PCNSL). PCNSL is a specific form of NHL that starts in the CNS rather than spreading there from other parts of the body. This type of lymphoma can cause neurological symptoms such as changes in behavior, memory problems, confusion, difficulty speaking or understanding language, weakness on one side of the body, and vision problems if the eyes are involved. Because PCNSL affects critical areas of the nervous system, it can lead to significant neurological deficits and requires prompt treatment. The symptoms reflect the areas of the brain or spinal cord that are affected by the lymphoma cells growing and disrupting normal function.
In addition to PCNSL, NHL can spread secondarily to the CNS from other lymphoma sites. This secondary involvement can cause similar neurological symptoms and is often more difficult to treat. Both primary and secondary CNS lymphoma are aggressive and can rapidly worsen neurological function if untreated.
Beyond direct tumor invasion, NHL can cause neurological complications through immune-mediated mechanisms known as paraneoplastic neurological syndromes (PNS). These occur when the body’s immune system, in response to the lymphoma, mistakenly attacks components of the nervous system. This immune cross-reactivity can lead to a variety of neurological problems, including sensory and motor neuropathies, cerebellar syndromes (which affect coordination and balance), limbic encephalitis (inflammation of brain areas involved in memory and emotions), and other rapidly progressing neurological deficits. These syndromes can be severe and sometimes precede the diagnosis of lymphoma, making them important clues for clinicians.
Peripheral neuropathy, which involves damage to the nerves outside the brain and spinal cord, is another common neurological complication in NHL. Patients may experience numbness, tingling, weakness, or pain in their hands and feet. This neuropathy can result from the lymphoma itself infiltrating nerves or from immune-mediated damage. It can also be caused or worsened by treatments such as chemotherapy, which are known to be neurotoxic.
Systemic effects of NHL and its treatment can also contribute to neurological problems. For example, metabolic disturbances such as low sodium levels (hyponatremia), high calcium levels (hypercalcemia), or vitamin deficiencies (like B12 or folate deficiency) can cause confusion, seizures, weakness, or sensory problems. These metabolic issues may worsen neurological symptoms and need to be identified and corrected promptly to prevent permanent damage.
Cancer treatments, including chemotherapy, radiation therapy, and newer immunotherapies, can themselves cause neurological side effects. Chemotherapy-induced peripheral neuropathy is common and can persist long after treatment ends. Radiation to the brain or spinal cord can cause inflammation and damage to healthy nervous tissue, leading to cognitive impairment, motor deficits, or other neurological issues. Immunotherapies, while promising in treating lymphoma, may also trigger immune-related neurological complications.
In some cases, NHL patients may develop severe neurological syndromes such as Guillain-Barré syndrome, a condition where the immune system attacks peripheral nerves, causing rapid weakness and sensory loss. This syndrome has been reported as an initial presentation or complication of NHL.
Overall, neurological complications in NHL are complex and multifactorial. They can arise from:
– Direct lymphoma involvement of the CNS or peripheral nerves
– Immune-mediated paraneoplastic syndromes attacking the nervous system
– Metabolic and systemic disturbances related to cancer or its treatment
– Neur
